Role of HDL Cholesterol and Estimates of HDL Particle Composition in Future Development of Type 2 Diabetes in the General Population: The PREVEND Study

被引:108
作者
Abbasi, Ali [1 ,2 ]
Corpeleijn, Eva [1 ]
Gansevoort, Ron T. [2 ]
Gans, Rijk O. B. [2 ]
Hillege, Hans L. [1 ]
Stolk, Ronald P. [1 ]
Navis, Gerjan [2 ]
Bakker, Stephan J. L. [2 ]
Dullaart, Robin P. F. [2 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands
关键词
HIGH-DENSITY-LIPOPROTEIN; BETA-CELL FUNCTION; APOLIPOPROTEIN-A-II; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; RISK-FACTORS; MELLITUS; DISEASE; PREDICTION; ATHEROSCLEROSIS;
D O I
10.1210/jc.2013-1680
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aims: High-density lipoproteins (HDLs) may directly stimulate beta-cell function and glucose metabolism. We determined the relationships of fasting high-density lipoprotein cholesterol (HDL-C), plasma apolipoprotein (apo) A-I and apoA-II, and HDL-C-to-apoA-I and HDL-C-to-apoA-II ratios, as estimates of HDL particle composition, with incident type 2 diabetes mellitus. Methods: A prospective study was carried out in the Prevention of Renal and Vascular End-Stage Disease (PREVEND) cohort after exclusion of subjects with diabetes at baseline (n = 6820; age, 28-75 years). The association of HDL-related variables with incident type 2 diabetes was determined by multivariate logistic regression analyses. Results: After a median follow-up of 7.7 years, 394 incident cases of type 2 diabetes mellitus were ascertained (5.8%). After adjustment for age, sex, family history of diabetes, body mass index, hypertension, alcohol, and smoking, odd ratios (ORs) for diabetes were 0.55 (95% confidence interval [CI], 0.47-0.64; P < .001), 0.81 (0.71-0.93; P = .002), 0.02 (0.01-0.06; P < .001), and 0.03 (0.01-0.060; P < .001) per 1-SD increase in HDL-C and apoA-I and in the HDL-C-to-apoA-I and the HDL-C-to-apoA-II ratios, respectively. In contrast, apoA-II was not related to incident diabetes (OR = 1.02; 95% CI, 0.90-1.16; P=0.71). The relationships of HDL-C and the ratios of HDL-C to apoA-I and HDL-C to apoA-II remained significant after further adjustment for baseline glucose and triglycerides (ORHDL = 0.74 [95% CI, 0.61-0.88], ORHDL/APOA-I = 0.14 [0.04-0.44], and ORHDL/APOA-II = 0.12 [0.04-0.36]; all P <= .001). Conclusions: Higher HDL-C, as well as higher HDL-C-to-apoA-I and HDL-C-to-apoA-II ratios are strongly and independently related to a lower risk of future type 2 diabetes.
引用
收藏
页码:E1352 / E1359
页数:8
相关论文
共 40 条
[21]   CARDIOVASCULAR RISK-FACTORS IN CONFIRMED PREDIABETIC INDIVIDUALS - DOES THE CLOCK FOR CORONARY HEART-DISEASE START TICKING BEFORE THE ONSET OF CLINICAL DIABETES [J].
HAFFNER, SM ;
STERN, MP ;
HAZUDA, HP ;
MITCHELL, BD ;
PATTERSON, JK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (21) :2893-2898
[22]   Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism [J].
Han, R. ;
Lai, R. ;
Ding, Q. ;
Wang, Z. ;
Luo, X. ;
Zhang, Y. ;
Cui, G. ;
He, J. ;
Liu, W. ;
Chen, Y. .
DIABETOLOGIA, 2007, 50 (09) :1960-1968
[23]   Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis [J].
Kontush, Anatol ;
Chapman, M. John .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :342-374
[24]   The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release [J].
Koren-Gluzer, Marie ;
Aviram, Michael ;
Meilin, Edna ;
Hayek, Tony .
ATHEROSCLEROSIS, 2011, 219 (02) :510-518
[25]   HDL and LDL cholesterol significantly influence β-cell function in type 2 diabetes mellitus [J].
Kruit, Janine K. ;
Brunham, Liam R. ;
Verchere, C. Bruce ;
Hayden, Michael R. .
CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (03) :178-185
[26]   Albuminuria Assessed From First-Morning-Void Urine Samples Versus 24-Hour Urine Collections as a Predictor of Cardiovascular Morbidity and Mortality [J].
Lambers Heerspink, Hiddo J. ;
Brantsma, Auke H. ;
de Zeeuw, Dick ;
Bakker, Stephan J. L. ;
de Jong, Paul E. ;
Gansevoort, Ron T. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 168 (08) :897-905
[27]  
Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4
[28]   HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN [J].
MATTHEWS, DR ;
HOSKER, JP ;
RUDENSKI, AS ;
NAYLOR, BA ;
TREACHER, DF ;
TURNER, RC .
DIABETOLOGIA, 1985, 28 (07) :412-419
[29]   Pharmacy data in epidemiological studies: an easy to obtain and reliable tool [J].
Monster, TBM ;
Janssen, WMT ;
de Jong, PE ;
de Jong-van den Berg, LTW .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (05) :379-384
[30]   International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes [J].
Nathan, David M. ;
Nathan, David M. ;
Balkau, Beverly ;
Bonora, Enzo ;
Borch-Johnsen, Knut ;
Buse, John B. ;
Colagiuri, Stephen ;
Davidson, Mayer B. ;
DeFronzo, Ralph ;
Genuth, Saul ;
Holman, Rury R. ;
Ji, Linong ;
Kirkman, Sue ;
Knowler, William C. ;
Schatz, Desmond ;
Shaw, Jonathan ;
Sobngwi, Eugene ;
Steffes, Michael ;
Vaccaro, Olga ;
Wareham, Nick ;
Zinman, Bernard ;
Kahn, Richard .
DIABETES CARE, 2009, 32 (07) :1327-1334